angioplasty

angioplastia a tronco de coronaria izquierda vs cirugia

Left Main Coronary Artery Angioplasty vs. Surgery: A Large Meta-Analysis

Courtesy of Dr. Carlos&nbsp;Fava. Around 5% of patients undergoing coronary angiography present severe left main coronary artery (LMCA) lesions.&nbsp;Myocardial revascularization surgery (MRS) is the preferred method&nbsp;for this group, although there is evidence from different randomized trials demonstrating the safety and efficacy of unprotected LMCA angioplasty, with results similar to those obtained through the traditional strategy.<a href="https://solaci.org/en/2017/01/16/left-main-coronary-artery-angioplasty-vs-surgery-a-large-meta-analysis/" title="Read more" >...</a>

pacientes anticoagulados por fibrilación auricular que reciben angioplastia tratamiento

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them

In patients with atrial fibrillation undergoing coronary angioplasty with stents, standard anticoagulation with vitamin K antagonists plus dual antiplatelet therapy with a P2Y12 inhibitor and aspirin reduces the risk of stent thrombosis and stroke, but increases the risk of bleeding. &nbsp; The effectiveness and safety of anticoagulation with rivaroxaban plus one or two antiplatelet agents<a href="https://solaci.org/en/2016/12/26/anticoagulated-patients-with-atrial-fibrillation-undergoing-angioplasty-how-to-treat-them/" title="Read more" >...</a>

ticagrelor vs prasugel

Ticagrelor vs. Prasugel: Similar Safety and Efficacy in Primary Angioplasty

No randomized head-to-head study comparing the efficacy and safety of ticagrelor and prasugrel has been carried out in the last 7&nbsp;years since these newer P2Y12 inhibitors first showed a higher efficacy relative to clopidogrel. &nbsp; This study was designed to compare the efficacy and safety of prasugrel and ticagrelor in patients with acute myocardial infarction<a href="https://solaci.org/en/2016/12/07/ticagrelor-vs-prasugel-similar-safety-and-efficacy-in-primary-angioplasty/" title="Read more" >...</a>

angioplastia en centros sin apoyo quirúrgico

Is Angioplasty at Centers Without Surgical Backup Safe?

Performing coronary angioplasties at hospitals without surgical backup seems to be safe for a wide variety of patients, from those presenting ST-segment elevation myocardial infarction to those undergoing elective procedures. &nbsp; This work responds to a long-running debate over whether centers without on-site surgery capabilities in case of complications can be considered as referral centers<a href="https://solaci.org/en/2016/12/01/is-angioplasty-at-centers-without-surgical-backup-safe/" title="Read more" >...</a>

Angioplastia a tronco de coronaria izquierda no es inferior a la cirugía

Left Main Coronary Artery Angioplasty Would Be Non-Inferior to Surgery

Courtesy of Dr. Carlos&nbsp;Fava. Left main coronary artery (LMCA) lesions have always been defined as high-risk, with surgery as treatment of choice. Drug-eluting stents (DES) have slowly changed that, but their use still lacks strong supporting evidence. &nbsp; The Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) study<a href="https://solaci.org/en/2016/11/09/left-main-coronary-artery-angioplasty-would-be-non-inferior-to-surgery/" title="Read more" >...</a>

Trombos residuales angioplastia primaria

Residual Thrombus After Aspiration Thrombectomy: Does It Affect the Outcome of Primary Angioplasty?

The aim of this study was to evaluate if the residual thrombus burden after aspiration thrombectomy may affect the outcome of primary angioplasty in patients with acute coronary syndrome with ST-segment elevation. &nbsp; The most recent studies on aspiration thrombectomy failed to show clinical benefit in patients with ST-segment elevation. This study is based on<a href="https://solaci.org/en/2016/10/20/residual-thrombus-after-aspiration-thrombectomy-does-it-affect-the-outcome-of-primary-angioplasty/" title="Read more" >...</a>

Prasugrel vs. Ticagrelor in Primary Angioplasty

The choice of prasugrel or ticagrelor for patients with acute myocardial infarction undergoing primary angioplasty makes no difference, at least in the short term. &nbsp; This study was terminated prematurely and thus lost statistical power, which means that any interpretation of the lack of difference between the two antiplatelet drugs must take into account such<a href="https://solaci.org/en/2016/09/07/prasugrel-vs-ticagrelor-in-primary-angioplasty/" title="Read more" >...</a>

Balloon Angioplasty vs. Sirolimus Eluting Stenting in Infrapopliteal Territory

Original Title: Wound Healing Outcomes and Health-Related Quality-of-Life Changes in the ACHILLES Trial1-Year Results From a Prospective Randomized Controlled Trial of Infrapopliteal Balloon Angioplasty Versus Sirolimus-Eluting Stenting in Patients With Ischemic Peripheral Arterial Disease. Reference: Konstantinos Katsanos et al. J Am Coll Cardiol Intv. 2016, online before print. &nbsp; The ACHILLES study (Comparing Angioplasty and DES<a href="https://solaci.org/en/2016/02/03/balloon-angioplasty-vs-sirolimus-eluting-stenting-in-infrapopliteal-territory/" title="Read more" >...</a>

Top